Search Results - "Mirenska, Anja"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2
  3. 3

    In situ detection of CD73+ CD90+ CD105+ lineage: Mesenchymal stromal cells in human placenta and bone marrow specimens by chipcytometry by Consentius, Christine, Mirenska, Anja, Jurisch, Anke, Reinke, Simon, Scharm, Markus, Zenclussen, Ana Claudia, Hennig, Christian, Volk, Hans‐Dieter

    Published in Cytometry. Part A (01-09-2018)
    “…Mesenchymal stromal cells (MSCs) support endogenous regeneration and present therefore promising opportunities for in situ tissue engineering. They can be…”
    Get full text
    Journal Article
  4. 4

    Immunophenotyping of cerebrospinal fluid cells by Chipcytometry by Hümmert, Martin W, Alvermann, Sascha, Gingele, Stefan, Gross, Catharina C, Wiendl, Heinz, Mirenska, Anja, Hennig, Christian, Stangel, Martin

    Published in Journal of neuroinflammation (25-05-2018)
    “…The gold standard in cerebrospinal fluid (CSF) cell immunophenotyping is flow cytometry. Nevertheless, the small amount of CSF cells and the invasive character…”
    Get full text
    Journal Article
  5. 5

    A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer by de la Fuente, Maria, PhD, Jones, Marie-Christine, PhD, Santander-Ortega, Manuel J., PhD, Mirenska, Anja, PhD, Marimuthu, Preethi, MSc, Uchegbu, Ijeoma, PhD, Schätzlein, Andreas, Dr med vet

    Published in Nanomedicine (01-02-2015)
    “…Abstract Gemcitabine is currently the standard therapy for pancreatic cancer. However, growing concerns over gemcitabine resistance mean that new combinatory…”
    Get full text
    Journal Article
  6. 6

    A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry by Teo, Jinkai, Mirenska, Anja, Tan, Meihui, Lee, Yifang, Oh, Janice, Hong, Lewis Z, Wnek, Richard, Yap, Yoon-Sim, Shih, Shian-Jiun, S Bhagat, Ali Asgar, Chin, Chih-Liang, Skibinski, David AG

    Published in Future science OA (01-11-2017)
    “…Expression of PD-L1 in the tumor is associated with more favorable responses to anti-PD-1 therapy in multiple cancers. However, obtaining tumor biopsies for…”
    Get full text
    Journal Article